Drug Type Small molecule drug |
Synonyms SPL-891, SPL-891.1 |
Target |
Action inhibitors |
Mechanism GSNOR inhibitors(S-nitrosoglutathione reductase inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Crohn Disease | Preclinical | United States | - | |
Diabetes Mellitus | Preclinical | United States | - | |
disorder of aging | Preclinical | United States | - | |
Heart Failure | Preclinical | United States | - | |
Idiopathic Pulmonary Fibrosis | Preclinical | United States | - | |
Inflammation | Preclinical | United States | - | |
Neoplasms | Preclinical | United States | - | |
Nonalcoholic Steatohepatitis | Preclinical | United States | - | |
Rheumatoid Arthritis | Preclinical | United States | - | |
Stroke | Preclinical | United States | - |